Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
Launched by ADVANCED MARKER DISCOVERY S.L. · Mar 17, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on developing a new blood test that could help detect colorectal cancer and advanced adenomas (which are growths that can lead to cancer) at an early stage. Researchers want to combine information from blood samples, including specific markers, with details about patients' health and risk factors to create a more accurate way to identify those at risk for these conditions.
To participate in this study, you need to be at least 18 years old and able to understand the information provided and agree to take part. You should also be planning to have a colonoscopy or surgery for a tumor. However, if you’ve had any type of cancer in the last five years, received certain treatments like chemotherapy, or have specific health conditions, you may not be eligible. Participants will provide blood samples and health information, which will help researchers learn more about the effectiveness of this new test. It’s an exciting opportunity to contribute to advancements in early cancer detection!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
- • Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).
- Exclusion Criteria:
- • Patients who had developed any type of cancer in the 5 years prior to their participation in this study.
- • Patients who have received previous chemotherapy or radiotherapy.
- • Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome.
- • Patients with inadequate bowel preparation for colonoscopy.
- • Patients who have undergone colonoscopy/polipectomy in the previous 5 years.
- • Patients with hemolyzed plasma.
About Advanced Marker Discovery S.L.
Advanced Marker Discovery S.L. is a leading biotechnology company focused on the development and commercialization of innovative diagnostic solutions and therapeutic biomarkers. With a commitment to advancing precision medicine, the company leverages cutting-edge technologies and extensive research to identify and validate novel biomarkers that enhance disease detection, monitoring, and treatment efficacy. Through strategic collaborations and robust clinical trial sponsorship, Advanced Marker Discovery aims to transform patient care by providing healthcare professionals with actionable insights and tools to improve clinical outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Santander, Cantabria, Spain
Zaragoza, Aragon, Spain
Oviedo, Asturias, Spain
Salamanca, Castilla Y Leon, Spain
Barcelona, Cataluña, Spain
Barcelona, Cataluña, Spain
Bilbao, Euskadi, Spain
San Sebastian, Euskadi, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported